RxDoctor Payments Data

Anson Lee, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Palo Alto, CANPI 1336237247

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $10,983 of the $15,293 with a category attached, or 71.8%. Atricure, Inc. accounts for 92.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $10,375 and has fallen 90.9% since, to $948 in 2025.

$15,293in general payments, 2019–2025

Across 64 payments — averaging $238.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$14K
  • Boston Scientific$573
  • Abbott$374
  • Edwards Lifesciences$170
  • Medtronic$79
  • Davol Inc.$26
$362,402in research payments, 2019–2025

Across 69 payments — averaging $5252.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$182K
  • AbbVie$87K
  • Atricure, Inc.$48K
  • Medtronic$45K

What the payments were for

  • Travel & lodging$10,98372%
  • Food & beverage$4,31028%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.48$14,070
Boston Scientific6$573
Abbott6$374
Edwards Lifesciences2$170
Medtronic1$79
Davol Inc.1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,293 in reported general payments places this provider in the 75th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California

Medicare billing

Part B allowed, 2024
$246,387
Medicare patients
144
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →